Center for Molecular & Cellular Studies of Ped Disease
分子中心
基本信息
- 批准号:6736329
- 负责人:
- 金额:$ 43.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-04-11 至 2007-11-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Our lack of understanding of the processes underlying pediatric illnesses and their appropriate therapy inflicts a heavy burden on children and their families. Our CHRCDA program will address this issue through training and mentoring young pediatric investigators. The Principal Investigator will be Dr. Michael M. Frank, Chair of the Department of Pediatrics, who has had a long successful career in training and mentoring. The day-to-day direction of the program will be provided by the Program Director, Dr. Page A. W. Anderson, Vice Chair of Research for the Department of Pediatrics. Dr. Delbert R. Wigfall, Associate Professor of Pediatrics, Associate Dean and Director of the Duke Institutional Multicultural Resource Center, will be our Minority Recruitment Advisor. The program will have two committees. The Internal Advisory Committee, chaired by Dr. Frank, is made up of members of our department and institution who are experienced investigators and mentors with leadership roles in our Institution. A subcommittee will assess and rank potential trainees. Recruitment of trainees from under-represented minorities will be a focus of our program. Dr. Frank will select the trainees. The Committee will interview the trainees and mentors on a regular basis. They, in concert with Drs. Frank and Anderson, will initiate any needed actions to support the progress of the trainees through the program. The External Advisory Board, made up of internationally recognized scientists and pediatricians from across the United States, will review on an annual basis the accomplishment of the program goals, the progress of the trainees and advise the Principal Investigator. Four trainees will be admitted the first year and four supported each year of the program. The training period will last from two to five years. The trainees' will dedicate over 75% of their time to the training program. The mentors will be selected based on their success in mentoring, the pediatric relevance of their research, leadership roles, and NIH funding. The trainees will be required to take courses in Responsible Conduct of Research, grant and manuscript writing, and core courses that include an Introduction to Statistics, Analysis of Genetic Data, and Molecular Genetics of Human Disease. The trainees will be required to give oral presentations to develop their communication skills. We are committed to recruiting these trainees to our department faculty. Our previous success in training and developing the scientific careers of junior investigators supports the long-term goal of this CHRCDA to develop successful academic pediatric scientists.
描述(由申请人提供):我们对儿科疾病的潜在过程及其适当治疗缺乏了解,这给儿童及其家庭带来了沉重的负担。我们的CHRCDA计划将通过培训和指导年轻的儿科研究人员来解决这个问题。首席调查员将是儿科主任迈克尔·M·弗兰克博士,他在培训和指导方面有着长期的成功职业生涯。该计划的日常指导将由计划主任、儿科研究部副主任佩奇·A·W·安德森博士提供。儿科学副教授、副院长兼杜克大学多元文化资源中心主任德尔伯特·R·威格福尔博士将担任我们的少数族裔招聘顾问。该计划将有两个委员会。内部咨询委员会由Frank博士担任主席,由我们部门和机构的成员组成,他们是我们机构中经验丰富的研究人员和具有领导作用的导师。一个小组委员会将对潜在的受训人员进行评估和排名。从代表性不足的少数民族中招募受训人员将是我们计划的重点。弗兰克博士将挑选受训人员。委员会将定期约谈受训人员和导师。他们将与弗兰克博士和安德森博士一起,发起任何必要的行动,以支持受训人员通过该计划取得进展。外部咨询委员会由来自美国各地的国际公认的科学家和儿科医生组成,将每年审查项目目标的实现情况、学员的进展情况,并向首席调查员提供建议。该计划的第一年将有四名学员入学,每年将有四名学员得到支持。培训时间从两年到五年不等。学员将把75%以上的时间投入到培训计划中。导师将根据他们在指导方面的成功、他们研究的儿科相关性、领导角色和NIH的资金来选择。学员将被要求参加负责任的研究行为、补助金和手稿写作课程,以及包括统计学导论、遗传数据分析和人类疾病分子遗传学在内的核心课程。学员将被要求进行口头陈述,以发展他们的沟通技能。我们致力于将这些实习生招募到我们的系教员中。我们之前在培训和发展初级研究人员的科学职业生涯方面取得的成功,支持了CHRCDA培养成功的学院型儿科科学家的长期目标。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michael M Frank其他文献
Michael M Frank的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Michael M Frank', 18)}}的其他基金
Complement Regulates the Humoral Response to HIV-1
补体调节对 HIV-1 的体液反应
- 批准号:
7764750 - 财政年份:2009
- 资助金额:
$ 43.2万 - 项目类别:
Complement Regulates the Humoral Response to HIV-1
补体调节对 HIV-1 的体液反应
- 批准号:
7685184 - 财政年份:2009
- 资助金额:
$ 43.2万 - 项目类别:
Duke Research Training Program for Pediatricians
杜克大学儿科医生研究培训计划
- 批准号:
6640666 - 财政年份:2002
- 资助金额:
$ 43.2万 - 项目类别:
Duke Research Training Program for Pediatricians
杜克大学儿科医生研究培训计划
- 批准号:
6734206 - 财政年份:2002
- 资助金额:
$ 43.2万 - 项目类别:
Duke Research Training Program for Pediatricians
杜克大学儿科医生研究培训计划
- 批准号:
6555261 - 财政年份:2002
- 资助金额:
$ 43.2万 - 项目类别:
相似国自然基金
Kidney injury molecular(KIM-1)介导肾小管上皮细胞自噬在糖尿病肾病肾间质纤维化中的作用
- 批准号:81300605
- 批准年份:2013
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
Molecular Plant
- 批准号:31224801
- 批准年份:2012
- 资助金额:20.0 万元
- 项目类别:专项基金项目
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data
- 批准号:31070748
- 批准年份:2010
- 资助金额:34.0 万元
- 项目类别:面上项目
Molecular Plant
- 批准号:31024802
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:专项基金项目
Cellular & Molecular Immunology
- 批准号:30824806
- 批准年份:2008
- 资助金额:20.0 万元
- 项目类别:专项基金项目
相似海外基金
Center: National Synthesis Center for Emergence in the Molecular and Cellular Sciences
中心:国家分子与细胞科学新兴综合中心
- 批准号:
2335029 - 财政年份:2024
- 资助金额:
$ 43.2万 - 项目类别:
Cooperative Agreement
Nevada Center of Biomedical Research Excellence in Molecular and Cellular Signal Transduction in the Cardiovascular System
内华达心血管系统分子和细胞信号转导生物医学卓越研究中心
- 批准号:
10399805 - 财政年份:2019
- 资助金额:
$ 43.2万 - 项目类别:
Nevada Center of Biomedical Research Excellence in Molecular and Cellular Signal Transduction in the Cardiovascular System Equipment Supplement
内华达心血管系统分子和细胞信号转导卓越生物医学研究中心设备补充
- 批准号:
10581428 - 财政年份:2019
- 资助金额:
$ 43.2万 - 项目类别:
Nevada Center of Biomedical Research Excellence in Molecular and Cellular Signal Transduction in the Cardiovascular System
内华达心血管系统分子和细胞信号转导生物医学卓越研究中心
- 批准号:
10077852 - 财政年份:2019
- 资助金额:
$ 43.2万 - 项目类别:
Nevada Center of Biomedical Research Excellence in Molecular and Cellular Signal Transduction in the Cardiovascular System
内华达心血管系统分子和细胞信号转导生物医学卓越研究中心
- 批准号:
10558647 - 财政年份:2019
- 资助金额:
$ 43.2万 - 项目类别:
Nevada Center of Biomedical Research Excellence in Molecular and Cellular Signal Transduction in the Cardiovascular System
内华达心血管系统分子和细胞信号转导生物医学卓越研究中心
- 批准号:
10332744 - 财政年份:2019
- 资助金额:
$ 43.2万 - 项目类别:
Coordinating Center: Molecular and Cellular Findings of Screen-Detected Lesions
协调中心:屏幕检测病变的分子和细胞发现
- 批准号:
9334552 - 财政年份:2015
- 资助金额:
$ 43.2万 - 项目类别:
Coordinating Center: Molecular and Cellular Findings of Screen-Detected Lesions
协调中心:屏幕检测病变的分子和细胞发现
- 批准号:
9630279 - 财政年份:2015
- 资助金额:
$ 43.2万 - 项目类别:
Cellular/Molecular Basis of Development: Research Center
细胞/分子发展基础:研究中心
- 批准号:
9359238 - 财政年份:2015
- 资助金额:
$ 43.2万 - 项目类别:
Cellular/Molecular Basis of Development: Research Center
细胞/分子发展基础:研究中心
- 批准号:
9359286 - 财政年份:2015
- 资助金额:
$ 43.2万 - 项目类别: